(UroToday.com) The 2026 ASCO annual meeting featured a urothelial carcinoma session and a presentation by Dr. Sandip Prasad discussing responses to UGN-102 across EORTC recurrence score groups in ...
Clear Cell Renal cell carcinoma (ccRCC) is the most common form of kidney cancer. The VHL tumor suppressor is lost or mutated in the majority of ccRCC and hereditary mutations in VHL predispose ...
Alicia Morgans outlines anemia management in the TALAPRO-3 regimen. The trial added talazoparib to enzalutamide in HRR-mutated metastatic hormone-sensitive prostate cancer, achieving 52% rPFS risk ...
Shilpa Gupta reports 3.5-year follow-up data from EV-302. Among all patients, 44% remained alive, double the chemotherapy arm, and more than 70% of complete responders were still alive. Complete ...
Kim Chi describes KLK2-comPAS, a trial investigating pasritamig, a bispecific IgG1 antibody that binds KLK2 and CD3. Phase one and two data in heavily pretreated patients showed radiographic ...
Comparative Analysis of Genitourinary Toxicity Following Bladder Outlet Obstruction Procedures in Patients Before Versus After Radiotherapy for Localized Prostate Cancer: A Retrospective Cohort Study ...
Factors Influencing Adherence to Intravesical Instillation Therapies for Non-Muscle-Invasive Bladder Cancer: A Scoping Review Protocol - Beyond the Abstract ...
Chronic prostatitis/chronic pelvic pain syndrome: Interplay of inflammatory mediators, "Beyond the Abstract," by Dan Lundh, Hans Hedelin, and Dennis Larsson ...
Relationship Between the Frequency of Electrocautery of Hunner Lesions and Changes in Bladder Capacity in Patients with Hunner Type Interstitial Cystitis - Beyond the Abstract ...
(UroToday.com) The 2026 ASCO annual meeting featured a kidney cancer rapid abstract session and a presentation by Dr. Darren Feldman discussing the final results of a phase 2 trial of cabozantinib + ...
The Kurt extraperitoneal ligamentopexy: A new surgical method with uterine preservation for pelvic organ prolapse, "Beyond the Abstract," by Sefa Kurt and Mehmet Tunc Canda ...
(UroToday.com) The 2026 SNMMI annual meeting featured a genitourinary radiotherapeutics session and a presentation by Dr. Abigail Pepin discussing a secondary analysis of the VISION trial assessing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results